Bharat Parenterals
add_icon

Bharat Parenterals

1,380.00
-18.20
(-1.30%)
Market Cap
951.06 Cr
PE Ratio
-35.29
Volume
1,300.00
Day High - Low
1,380.00 - 1,370.00
52W High-Low
1,667.20 - 880.25
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
951.06 Cr
EPS
-39.62
PE Ratio
-35.29
PB Ratio
2.99
Book Value
467.55
EBITDA
15.82
Dividend Yield
0.07 %
Industry
Healthcare
Return on Equity
-12.88
Debt to Equity
0.64
Forecast For
Actual

Company News

View All News
Caret
negative
Bharat Parenterals posted Q4 FY26 consolidated revenue of ₹99.6 crore vs ~₹100 crore YoY, with net loss at ₹4.8 crore vs ₹4.7 crore loss in Q4 FY25.
neutral
Bharat Parenterals Limited published newspaper advertisements regarding proposed share transfers in physical form pursuant to SEBI circular dated January 30, 2026.
negative
Bharat Parenterals Gets 5 FDA ObservationsApr 21, 2026
U.S. FDA conducted surprise inspection at InnoXel Lifesciences facility, issued 5 VAI observations. Company awaits final Establishment Inspection Report from regulatory authority.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,780.10
#1 4,27,105.62
37.30
#1 58,220.10
6.38
#1 11,565
25.80
42.78
6,596.50
1,75,116.35
67.97
10,560.00
8.73
2,520
13.44
47.99
4,339.90
1,46,881.94
69.16
13,886.20
20.34
2,138
-26.91
48.37
1,398.70
1,12,984.28
28.76
27,711.70
-2.46
3,783
-55.32
58.01
1,084.60
1,09,136.14
21.14
26,719.70
13.65
5,242
7.82
70.26
1,267.50
1,05,791.00
25.35
33,593.30
-0.44
3,998
-86.05
42.70
2,249.80
1,02,825.58
#1 19.30
27,487.50
19.98
5,345
#1 87.72
43.27
2,353.00
97,133.03
50.52
14,277.60
12.03
1,750
31.75
48.78
1,463.60
85,006.13
23.88
33,384.70
3.21
3,376
1.99
54.11
1,427.20
77,048.33
84.57
6,812.90
#1 21.03
884
21.18
79.30
Growth Rate
Revenue Growth
-1.87 %
Net Income Growth
-34.42 %
Cash Flow Change
-478.56 %
ROE
-392.06 %
ROCE
-167.54 %
EBITDA Margin (Avg.)
9.58 %

Quarterly Financial Results

Quarterly Financials
Dec 2016
Sept 2017
Dec 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
27
37
32
40
52
94
46
53
53
77
57
57
62
52
42
63
63
40
55
28
88
63
51
72
62
61
71
95
76
75
106
117
68
67
103
Expenses
26
32
28
32
39
82
38
44
45
63
48
47
51
44
38
50
50
36
48
24
73
56
45
60
56
53
67
88
79
69
102
102
64
64
100
EBITDA
2
5
4
9
13
12
8
9
8
14
9
11
11
8
4
12
13
4
7
3
16
6
7
13
7
8
4
7
-4
7
4
15
4
3
3
Operating Profit %
6 %
13 %
13 %
15 %
23 %
9 %
10 %
11 %
9 %
15 %
13 %
15 %
14 %
11 %
6 %
17 %
17 %
7 %
8 %
7 %
11 %
4 %
12 %
15 %
7 %
11 %
1 %
5 %
-11 %
5 %
2 %
12 %
1 %
3 %
-1 %
Depreciation
1
2
1
1
2
2
2
2
2
2
1
1
1
2
2
2
2
2
2
2
2
1
1
2
2
2
4
9
9
9
9
9
9
9
9
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
3
3
3
4
4
3
3
3
Profit Before Tax
2
3
4
7
11
11
6
7
6
12
7
9
9
6
2
10
11
2
5
2
14
4
4
10
5
6
-1
-5
-15
-6
-8
3
-7
-8
-8
Tax
0
1
1
2
7
4
1
2
2
4
0
3
3
1
1
3
3
1
1
0
4
1
2
3
2
2
1
4
2
2
1
3
1
1
-0
Net Profit
2
3
3
5
4
7
5
5
4
8
7
7
6
5
2
8
8
1
4
1
10
3
2
7
2
4
-3
-9
-18
-8
-9
-1
-9
-10
-8
EPS in ₹
2.94
4.62
5.45
9.15
7.46
11.34
9.13
8.29
7.29
14.11
12.45
11.58
11.26
9.46
3.29
13.49
13.88
2.32
7.04
2.03
17.19
4.94
4.24
13.03
6.07
6.45
-0.62
-2.11
-27.00
-11.42
-14.40
-1.00
-12.48
-14.03
-11.84

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
120
111
132
159
188
199
226
350
504
649
613
Fixed Assets
35
31
34
35
33
45
41
42
211
252
238
Current Assets
72
64
91
118
132
148
144
184
262
356
310
Capital Work in Progress
0
0
0
1
12
0
26
99
25
31
34
Investments
0
1
1
2
0
43
12
0
0
5
85
Other Assets
86
79
98
121
142
111
148
209
269
360
0
Total Equity & Liabilities
120
111
132
159
188
199
226
350
504
649
613
Current Liabilities
56
43
57
61
66
44
42
120
190
219
157
Non Current Liabilities
7
4
2
4
3
11
14
13
76
90
144
Total Equity
57
64
73
94
118
144
170
218
238
339
322
Reserve & Surplus
51
58
67
88
113
138
160
177
191
324
315
Share Capital
6
6
6
6
6
6
6
6
6
7
7

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
-11
2
7
-1
-8
2
4
1
-8
Investing Activities
0
-2
-8
-9
-13
-43
-7
-78
-105
-137
Operating Activities
0
-2
6
20
14
25
-1
22
-5
-27
Financing Activities
0
-8
4
-4
-3
11
9
61
110
156

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
74.42 %
74.42 %
74.42 %
74.42 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.26 %
73.27 %
65.35 %
67.20 %
67.20 %
67.20 %
67.19 %
67.19 %
67.19 %
67.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.08 %
0.08 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.57 %
0.54 %
0.54 %
0.54 %
0.54 %
0.54 %
0.54 %
1.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.56 %
16.38 %
16.23 %
15.46 %
15.55 %
15.65 %
14.85 %
14.70 %
13.31 %
13.21 %
13.00 %
12.99 %
13.61 %
13.60 %
20.07 %
19.00 %
19.20 %
18.94 %
19.31 %
19.27 %
19.21 %
18.86 %
Others
9.01 %
9.19 %
9.34 %
10.11 %
10.60 %
10.50 %
11.30 %
11.45 %
12.84 %
12.95 %
13.15 %
13.16 %
13.11 %
13.13 %
13.92 %
13.18 %
12.95 %
13.21 %
12.85 %
12.89 %
12.94 %
12.80 %
No of Share Holders
0
2,572
3,122
2,912
2,805
2,796
2,765
2,700
2,515
2,485
2,481
2,397
2,497
2,727
2,748
2,750
3,116
3,177
3,231
3,205
3,172
3,095

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.75 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.1 0.11 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Sept 2023 DIVIDEND Dividend
₹ 0.75 /share
25 Sept 2023 328.10 551.50
21 May 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
21 May 2024 1,705.95 1,511.15
25 Jun 2024 DIVIDEND Dividend
₹ 1.00 /share
25 Jun 2024 1,494.15 1,444.00
02 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
02 Jul 2024 1,409.00 1,500.00
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2024 1,440.00 1,355.45
03 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Feb 2025 1,397.75 1,292.25
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 987.90 1,089.30
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2025 1,550.00 1,550.00
19 Sept 2025 DIVIDEND Dividend
₹ 1.00 /share
19 Sept 2025 1,089.30 1,319.95
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 1,355.00 1,300.00
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 1,222.45 1,097.35
30 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2026 1,107.05 1,096.10
18 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 May 2026 1,212.65 1,252.05

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Compliances-Reg.24(A)-Annual Secretarial Compliance10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 19, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 18, 2026
Re-Appointment Of Cost Auditor And Internal Auditor Of The Company.May 18, 2026
Corporate Action-Board approves DividendMay 18, 2026
Audited Financial Results For The Quarter And Year Ended March 31 2026May 18, 2026
Board Meeting Outcome for Outcome Of Board MeetingMay 18, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2026
Board Meeting Intimation for Approving Audited Financial Results For The Quarter And Year Ended March 31 2026 And Recommendation Of Final Dividend On Equity Shares.May 09, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2026
Clarification On Price MovementApr 10, 2026
Clarification sought from Bharat Parenterals LtdApr 10, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 08, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Closure of Trading WindowMar 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Month Ended On December 31 2025.Jan 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 01, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 10, 2025
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Dec 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Nov 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Nov 12, 2025
For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Board Meeting Outcome for For Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.Nov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025

Technical Indicators

RSI(14)
Neutral
64.69
ATR(14)
Volatile
77.86
STOCH(9,6)
Neutral
69.36
STOCH RSI(14)
Neutral
41.99
MACD(12,26)
Bullish
3.49
ADX(14)
Strong Trend
25.07
UO(9)
Bearish
44.42
ROC(12)
Uptrend And Accelerating
11.67
WillR(14)
Overbought
-0.84